Mark Rothera, Chief Commercial Officer at PTC THERAPEUTICS, INC. (PTCT), bought 25,000 shares at $15.00 ($375K) on 2013-06-25, disclosed to the SEC on 2013-06-27.
Open-market purchase of $375k PTCT by Chief Commercial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| PTCT | SELL | 2015-03-18 | $820K | — | Filing → |
| PTCT | SELL | 2015-03-13 | $23K | — | Filing → |
| PTCT | SELL | 2015-02-25 | $2.4M | — | Filing → |